The Substantial Clinical Benefit Threshold for SRS-22R Domains After Surgical Treatment of Adult Spinal Deformity.

@article{Crawford2016TheSC,
  title={The Substantial Clinical Benefit Threshold for SRS-22R Domains After Surgical Treatment of Adult Spinal Deformity.},
  author={Charles H. Crawford and Steven Glassman and Keith H. Bridwell and Leah Yacat Carreon},
  journal={Spine deformity},
  year={2016},
  volume={4 5},
  pages={
          373-377
        }
}
STUDY DESIGN Longitudinal cohort. OBJECTIVES To determine Substantial Clinical Benefit (SCB) thresholds for the SRS22R domains in patients undergoing adult spinal deformity surgery. SUMMARY OF BACKGROUND DATA The Scoliosis Research Society 22R (SRS22R) has been shown to be reliable, valid, and responsive to change in adult spinal deformity patients. Although the minimal clinically important difference (MCID) is commonly used to quantify a threshold of improvement, it could be considered a… CONTINUE READING